Marinus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, which offers a new mechanism of action, an extensive safety database, and convenient dosing to improve the lives of patients suffering from drug-resistant seizures and neuropsychiatric disorders.


Clinical Trials

Physicians and patients learn more about ganaxolone and Marinus Pharmaceuticals’ clinical trials here.

View Pipeline >

Follow Us on Twitter

Beverly Hanrahan's Twitter avatar
Beverly Hanrahan

● 150K new cases of #epilepsy yearly. You can help save lives. #TalkAboutEpilepsy & watch #Netathon2017: t.co/IB8DhTiJPS

Retweeted by Marinus Pharma